the aid library

LIST OPTIONS

Filter

4917

Download (831)

View PDF (627)

NACA Annual Report: Report of Achievement for the Year 2014

National Agency for the Control of AIDS (NACA), Abuja Nigeria (2014) C1

Download (1049)

View PDF (1475)

Ending Cholera. A global roadmap to 2030
recommended

Global Task Force on Cholera Control (GTFCC) (2017) C_WHO

Ending Cholera—A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a world in which cholera is no longer a threat to public health

Download (800)

View PDF (1099)

Guidelines for the Management of Adverse Drug Effects of Antimycobacterial Agents

Lawrence Flick Memorial Tuberculosis Clinic, Philadelphia Tuberculosis Control Program (1998) C2

Download (367)

View PDF (951)

Evaluation of ECDC Ebola deployment in Guinea

Kokki, M.; Safrani, N. European Centre for Disease Prevention and Control (2017) C1

Download (260)

View PDF (423)

Improving Prison Conditions by Strengthening the Monitoring of HIV, HCV, TB and Harm Reduction (Spain)

C. F. Bessa, G. N. lazo, G. V. Sauret Observatory of the Penal System and Human Rights (University of Barcelona); European Union (2015) C2

Mapping Report - Catalonia (Spain).

Download (495)

View PDF (691)

BCG Vaccine U.S.P. (For percutaneous use)

U.S. Food & Drug Administration; U.S. Department of Health and Human Services (2017) C2

Accessed December 2017

Download (558)

View PDF (938)

Nigeria: Standard Operating Procedures for Lassa Fever Case Management

Nigeria Centre for Disease Control (2017) C2

Download (226)

View PDF (339)

A Guide to Operating Public Shelters in a Radiation Emergency

Ansari, Armin; Caspary, Kevin Centers for Disease Control and Prevention (CDC) (2015) C_CDC

This guide is intended for shelter operators, planners, and staff, as well as emergency managers, public health professionals, and radiation protection professionals who participate in shelter planning and could be called upon to support shelter operations. This guide provides information on the inc... more

Download (277)

View PDF (265)

Primary Health Care Sysems (PRIMASYS). Case study from Ethiopia

Alliance for Health Policy and System Research; World Health Organization WHO (2017) C_WHO

Download (144)

View PDF (195)

Preventing Suicide: A Technical Package of Policy, Programs, and Practices

Stone, D.; K. Holland, B. Bartholow, et al. Centers for Disease Control and Prevention CDC (2017) C_CDC

This technical package represents a select group of strategies based on the best available evidence to help communities and states sharpen their focus on prevention activities with the greatest potential to prevent suicide

Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV

European Centre for Disease Prevention and Control ECDC (2020) C1

This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ... more

Download (93)

View PDF (143)

Disinfection of environments in healthcare and non-healthcare settings potentially contaminated with SARS-CoV-2

European Centre for Disease Prevention and Control ECDC (2020) C1

This document provides guidance to EU/EEA Member States on environmental cleaning in healthcare and non-healthcare settings during the COVID-19 pandemic.

Contact tracing: Public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union -third update

European Centers for Disease Control and Prevention ECDC (2020) C_CDC

This document aims to help EU/EEA public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 cases. It outlines the key steps of contact tracing, including contact identification, listing and follow-up, in the context of the COVID-... more

Guidelines for the implementation of non-pharmaceutical interventions against COVID-19

European Centre for Disease Prevention and Control ECDC (2016) C1

Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the... more

Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020

Honein MA, Christie A, Rose DA, et al. Centers for Disease Control and Prevention CDC (2020) C_CDC

MMWR Morb Mortal Wkly Rep. ePub: 4 December 2020. DOI: http://dx.doi.org/10.15585/mmwr.mm6949e2

ECDC rapid assessment of laboratory practices and needs related to COVID-19

European Centre for Disease Prevention and Control ECDC (2021) C1

18 Janaury 2021 EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021. Many countries are adding rapid antigen detection tests (RADT) to their ... more

National Implementation Guidelines for HIV and STI Programming Among Young Key Populations

NASCOP (National AIDS & STI Control Programme), Kenya (2018) CC

These guidelines were developed as part of Kenya's fast-track plan to end AIDS among adolescents and young people. Based on research into adolescent and young key populations in Kenya and elsewhere, they outline a package of HIV prevention services, and emphasize the need to combine biobehavioural i... more

Download (138)

View PDF (149)

Faith Sector Key HIV Messages for Mainstreaming

Ministry of Health, Kenya; National AIDS Control Council (2018) C1

The National AIDS Control Council recognizes the growing, organized and progressive inter-faith religious voice in the spheres of governance and development in Kenya. Across the country, the Faith Sector has been involved in HIV prevention, tre... more

Implementation Guide for COVID-19 Vaccines in Africa
recommended

African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al. (2021) C1

“Guide to facilitate the implementation of the WHO/UNICEF “Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines” for Africa t contains action-oriented lists of critical topics to address and checklists tailored to the context of African Union Member States. ... more

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Ending Cholera. A global roadmap to 2030 recommended

Implementation Guide for COVID-19 Vaccines in Africa recommended

Ending Cholera. A global roadmap to 2030
recommended

Implementation Guide for COVID-19 Vaccines in Africa
recommended